CD2-negative lymphoma-associated T-cells: a potential mechanism of immune-evasion in diffuse large B-cell lymphoma.


Journal

Virchows Archiv : an international journal of pathology
ISSN: 1432-2307
Titre abrégé: Virchows Arch
Pays: Germany
ID NLM: 9423843

Informations de publication

Date de publication:
Oct 2022
Historique:
received: 24 02 2022
accepted: 18 05 2022
revised: 04 05 2022
pubmed: 28 5 2022
medline: 12 10 2022
entrez: 27 5 2022
Statut: ppublish

Résumé

CD2 is a costimulatory protein expressed in all mature T/NK-cells, in particular memory T-cells. CD58 (or LFA-3) is the receptor for CD2 and is ubiquitously expressed. CD2-CD58 interaction has key functions in T-cell activation and organization of the immunological synapse between T- and antigen-presenting cells. Cancer cells have developed multiple mechanisms to evade immune surveillance. Loss of CD58 expression is one frequently reported in diffuse large B-cell lymphomas (DLBCL). On the other hand, in non-hematological neoplasms, tumor infiltrating lymphocytes (TILs) with reduced expression of CD2 have been associated with defective cytotoxicity and T-cell exhaustion. Here, we reported a case of DLBCL involving the jejunal mucosa associated with a rim of cytotoxic reactive T-cells with features of immune evasion (CD2- and TCR-) and T-cell exhaustion (PD1 + high). This case likely exemplifies a previously unrecognized immune evasion mechanism in lymphoma involving a decreased CD2 expression in the lymphoma-associated T-cells.

Identifiants

pubmed: 35622145
doi: 10.1007/s00428-022-03348-x
pii: 10.1007/s00428-022-03348-x
doi:

Substances chimiques

CD2 Antigens 0
CD58 Antigens 0
Receptors, Antigen, T-Cell 0

Types de publication

Case Reports Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

659-663

Informations de copyright

© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Références

Challa-Malladi M, Lieu YK, Califano O, Holmes AB, Bhagat G, Murty VV, Dominguez-Sola D, Pasqualucci L, Dalla-Favera R (2011) Combined genetic inactivation of beta2-Microglobulin and CD58 reveals frequent escape from immune recognition in diffuse large B cell lymphoma. Cancer Cell 20:728–740. https://doi.org/10.1016/j.ccr.2011.11.006
doi: 10.1016/j.ccr.2011.11.006 pubmed: 22137796 pmcid: 3660995
Demetriou P, Abu-Shah E, Valvo S, McCuaig S, Mayya V, Kvalvaag A, Starkey T, Korobchevskaya K, Lee LYW, Friedrich M, Mann E, Kutuzov MA, Morotti M, Wietek N, Rada H, Yusuf S, Afrose J, Siokis A, Oxford IBDCI, Meyer-Hermann M, Ahmed AA, Depoil D, Dustin ML (2020) A dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals. Nat Immunol 21:1232–1243. https://doi.org/10.1038/s41590-020-0770-x
doi: 10.1038/s41590-020-0770-x pubmed: 32929275 pmcid: 7611174
Demetriou P, Abu-Shah E, Valvo S, McCuaig S, Mayya V, Kvalvaag A, Starkey T, Korobchevskaya K, Lee LYW, Friedrich M, Mann E, Kutuzov MA, Morotti M, Wietek N, Rada H, Yusuf S, Afrose J, Siokis A, Oxford IBDCI, Meyer-Hermann M, Ahmed AA, Depoil D, Dustin ML (2021) Author correction: a dynamic CD2-rich compartment at the outer edge of the immunological synapse boosts and integrates signals. Nat Immunol 22:99. https://doi.org/10.1038/s41590-020-00825-w
doi: 10.1038/s41590-020-00825-w pubmed: 33122852
Dustin ML, Olszowy MW, Holdorf AD, Li J, Bromley S, Desai N, Widder P, Rosenberger F, van der Merwe PA, Allen PM, Shaw AS (1998) A novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-cell contacts. Cell 94:667–677. https://doi.org/10.1016/s0092-8674(00)81608-6
doi: 10.1016/s0092-8674(00)81608-6 pubmed: 9741631
Koneru M, Monu N, Schaer D, Barletta J, Frey AB (2006) Defective adhesion in tumor infiltrating CD8+ T cells. J Immunol 176:6103–6111. https://doi.org/10.4049/jimmunol.176.10.6103
doi: 10.4049/jimmunol.176.10.6103 pubmed: 16670319
McKinney EF, Lee JC, Jayne DR, Lyons PA, Smith KG (2015) T-cell exhaustion, co-stimulation and clinical outcome in autoimmunity and infection. Nature 523:612–616. https://doi.org/10.1038/nature14468
doi: 10.1038/nature14468 pubmed: 26123020 pmcid: 4623162
Menter T, Tzankov A (2018) Mechanisms of immune evasion and immune modulation by lymphoma cells. Front Oncol 8:54. https://doi.org/10.3389/fonc.2018.00054
doi: 10.3389/fonc.2018.00054 pubmed: 29564225 pmcid: 5845888
Otsuka Y, Nishikori M, Arima H, Izumi K, Kitawaki T, Hishizawa M, Takaori-Kondo A (2020) EZH2 inhibitors restore epigenetically silenced CD58 expression in B-cell lymphomas. Mol Immunol 119:35–45. https://doi.org/10.1016/j.molimm.2020.01.006
doi: 10.1016/j.molimm.2020.01.006 pubmed: 31962268
Palomero T, Couronne L, Khiabanian H, Kim MY, Ambesi-Impiombato A, Perez-Garcia A, Carpenter Z, Abate F, Allegretta M, Haydu JE, Jiang X, Lossos IS, Nicolas C, Balbin M, Bastard C, Bhagat G, Piris MA, Campo E, Bernard OA, Rabadan R, Ferrando AA (2014) Recurrent mutations in epigenetic regulators, RHOA and FYN kinase in peripheral T cell lymphomas. Nat Genet 46:166–170. https://doi.org/10.1038/ng.2873
doi: 10.1038/ng.2873 pubmed: 24413734 pmcid: 3963408
Sanchez-Madrid F, Krensky AM, Ware CF, Robbins E, Strominger JL, Burakoff SJ, Springer TA (1982) Three distinct antigens associated with human T-lymphocyte-mediated cytolysis: LFA-1, LFA-2, and LFA-3. Proc Natl Acad Sci U S A 79:7489–7493. https://doi.org/10.1073/pnas.79.23.7489
doi: 10.1073/pnas.79.23.7489 pubmed: 6984191 pmcid: 347365
Siokis A, Robert PA, Demetriou P, Dustin ML, Meyer-Hermann M (2018) F-actin-driven CD28-CD80 localization in the immune synapse. Cell Rep 24:1151–1162. https://doi.org/10.1016/j.celrep.2018.06.114
doi: 10.1016/j.celrep.2018.06.114 pubmed: 30067972

Auteurs

Anindita Ghosh (A)

Department of Pathology and Laboratory Medicine, The University of Texas Health Science Center, Houston, TX, USA.

Mario L Marques-Piubelli (ML)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Xiaoqiong Wang (X)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Tiffany G Sheu (TG)

Department of Pathology and Genomic Medicine, Houston Methodist Hospital, Houston, TX, USA.

Joanne Cheng (J)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Khaja Khan (K)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Wei Lu (W)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

John Manning (J)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Guilin Tang (G)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Luisa M Solis (LM)

Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.

Francisco Vega (F)

Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. fvega@mdanderson.org.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH